Issuer · CIK 0001730430
KNSA — Kiniksa Pharmaceuticals International, plc
Recent filings
- Jun 2, 2026·Form 4·Other—
KNSA/Kiniksa Pharmaceuticals International, plc
Quart Barry D · director
Mechanical filing
AI thesis skipped - Jun 2, 2026·Form 4·Other—
KNSA/Kiniksa Pharmaceuticals International, plc
Popovits Kimberly J · director
Mechanical filing
AI thesis skipped - Jun 2, 2026·Form 4·Other—
KNSA/Kiniksa Pharmaceuticals International, plc
McCain Tracey L · director
Mechanical filing
AI thesis skipped - Jun 2, 2026·Form 4·Other—
KNSA/Kiniksa Pharmaceuticals International, plc
Levy Richard S · director
Mechanical filing
AI thesis skipped - Jun 2, 2026·Form 4·Other—
KNSA/Kiniksa Pharmaceuticals International, plc
Cole G Bradley · director
Mechanical filing
AI thesis skipped - Jun 2, 2026·Form 4·Other—
KNSA/Kiniksa Pharmaceuticals International, plc
BAKER BROS. ADVISORS LP · director
Mechanical filing
AI thesis skipped - Apr 8, 2026·Form 4·Other$41.4K
KNSA/Kiniksa Pharmaceuticals International, plc
Tessari Eben · CHIEF STRATEGY OFFICER
Mechanical filing
AI thesis skipped - Feb 4, 2026·Form 4·Sell$567.1K
KNSA/Kiniksa Pharmaceuticals International, plc
Quart Barry D · director
8conviction